HGF/c-MET axis enhanced ETV1 expression via ERK1/2-ELK1 pathway, leading to PTK2 and c-MET upregulation and subsequent augmented HCC metastasis. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.